Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Short-Term Debt issuances

Growth Metrics

Others

Balance Labs (BLNC) Gains from Investment Securities (2016 - 2025)

Balance Labs filings provide 7 years of Gains from Investment Securities readings, the most recent being $780264.0 for Q4 2025.

On a quarterly basis, Gains from Investment Securities changed N/A to $780264.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $780264.0, a N/A change, with the full-year FY2025 number at $780264.0, changed N/A from a year prior.
Gains from Investment Securities hit $780264.0 in Q4 2025 for Balance Labs, up from $5500.0 in the prior quarter.
In the past five years, Gains from Investment Securities ranged from a high of $780264.0 in Q4 2025 to a low of $5500.0 in Q1 2021.